MétaCan
Menu
Back to cohort
Record W4411330989 · doi:10.14785/lymphosign-2025-0004

Transition from subcutaneous to intravenous immunoglobulin therapy in primary immunodeficiency: A case series highlighting patient-centered treatment optimization

2025· article· en· W4411330989 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.
venuePublished in a venue whose home country is Canada.

Bibliographic record

VenueLymphoSign Journal · 2025
Typearticle
Languageen
FieldImmunology and Microbiology
TopicImmunodeficiency and Autoimmune Disorders
Canadian institutionsHospital for Sick Children
Fundersnot available
KeywordsPrimary immunodeficiencyMedicineCommon variable immunodeficiencyAntibodySeries (stratigraphy)Human immunodeficiency virus (HIV)ImmunologyBiology

Abstract

fetched live from OpenAlex

Background: Immunoglobulin replacement therapy (IgRT) is a cornerstone therapy for managing primary immuneodeficiency (PID) and other immune-related disorders. While both intravenous immunoglobulin (IVIg) and subcutaneous immunoglobulin (SCIg) are effective, patient tolerance and preferences can influence treatment success. Objective: To evaluate the reasons for switching from SCIg to IVIg in 4 PID patients and to assess the resulting clinical outcomes and patient-reported experiences. Methods: This case series includes 4 individuals with PID who transitioned from SCIg to IVIg due to persistent side effects. Data were collected on adverse reactions during SCIg therapy, changes in immunoglobulin (IgG) levels, and patient-reported outcomes following the switch to IVIg. Results: All patients experienced adverse effects with SCIg, including headaches, fatigue, shortness of breath, and difficulty managing infusions. Following the transition to IVIg, patients reported improved tolerance, fewer side effects, and greater convenience with treatment schedules. IgG levels remained stable or improved post-switch, indicating sustained therapeutic efficacy. Conclusion: IVIg is a viable and effective alternative for PID patients who experience intolerance to SCIg. Individualized IgRT strategies that consider side effect profiles and patient preferences can enhance treatment adherence and quality of life. Statement of Novelty: This case series highlights patient-driven transitions from SCIg to IVIg therapy in primary immunodeficiency patients. This study provides insights into a subset of patients who experience persistent SCIg-related side effects, underscoring the importance of personalized IgRT approaches based on patient tolerance and quality-of-life considerations.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.472
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0010.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.007
GPT teacher head0.206
Teacher spread0.199 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it